Quick Answer
Milestone Pharmaceuticals Inc. reported Stockholders Equity of $41.77 million for fiscal year 2025.
Milestone Pharmaceuticals Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $41.77M | +217.7% |
| 2024 | $13.15M | -21.6% |
| 2023 | $16.77M | -74.7% |
| 2022 | $66.35M | -41.1% |
| 2021 | $112.60M | -21.3% |
| 2020 | $143.12M | +24.5% |
| 2019 | $114.92M | +37.5% |
| 2018 | $83.55M | +221.5% |
| 2017 | $25.98M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $20.50M | -14.6% | +215.5% |
| June 30, 2025 | -$17.75M | -155.5% | -189.8% |
| March 31, 2025 | -$6.12M | -115.3% | -146.6% |
| December 31, 2024 | $13.15M | -21.6% | -45.2% |
| September 30, 2024 | $24.01M | -15.8% | -24.9% |
| June 30, 2024 | $31.98M | -20.9% | -19.9% |
| March 31, 2024 | $39.92M | -26.0% | +138.0% |
| December 31, 2023 | $16.77M | -74.7% | -41.2% |
- Milestone Pharmaceuticals Inc. showed an increase of +217.7% in Stockholders Equity compared to the prior fiscal year.
- Over the 2017–2025 period, Milestone Pharmaceuticals Inc.’s stockholders equity has grown by 60.7% (from $25.98 million to $41.77 million).
- The most recent figure is from Milestone Pharmaceuticals Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: